ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Otolaryngology

Top Otolaryngology Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
JUDYANN KRENNING M.D.

Otolaryngology

1,744

$114K

362
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 21%

$65
Average prescription price

Avg: $51

SEAN BAILEY M.D.

Otolaryngology

1,469

$126K

375
312 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 21%

$86
Average prescription price

Avg: $51

GEORGE LIVERMORE M.D.

Otolaryngology

1,358

$85K

420
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 21%

$63
Average prescription price

Avg: $51

ANTHONY BENTLEY D.O.

Otolaryngology

1,350

$41.3K

320
225 are 65+

17%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 10%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 21%

$31
Average prescription price

Avg: $51

ALLAN ALLPHIN MD

Otolaryngology

1,224

$55K

348
225 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 21%

$45
Average prescription price

Avg: $51

FREDERIC PUGLIANO M.D.

Otolaryngology

1,166

$56.8K

350
288 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 21%

$49
Average prescription price

Avg: $51

ERIC CHRISTENSEN MD

Otolaryngology

1,156

$49.8K

221
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 21%

$43
Average prescription price

Avg: $51

MARK COVINGTON M.D.

Otolaryngology

1,090

$51.7K

248
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 21%

$47
Average prescription price

Avg: $51

JOHN DAHM MD

Otolaryngology

1,053

$53.8K

333
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$51
Average prescription price

Avg: $51

OSCAR HANTZ M.D.

Otolaryngology

965

$46.5K

289
224 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$48
Average prescription price

Avg: $51

JOHN CONOYER M.D.

Otolaryngology

950

$32.7K

370
311 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 21%

$34
Average prescription price

Avg: $51

JAMES HARTMAN M.D.

Otolaryngology

904

$44K

253
208 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 21%

$49
Average prescription price

Avg: $51

REBECCA BRANDSTED MD

Otolaryngology

855

$45.5K

247
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 21%

$53
Average prescription price

Avg: $51

JAMES MCILWAINE M.D.

Otolaryngology

810

$46.6K

266
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 21%

$58
Average prescription price

Avg: $51

SHELDON DAVIS M.D.

Otolaryngology

768

$45.7K

305
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 21%

$60
Average prescription price

Avg: $51

STEVEN WEST M.D.

Otolaryngology

724

$37.5K

311
258 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 21%

$52
Average prescription price

Avg: $51

JOHN CONOYER M.D.

Otolaryngology

704

$24.9K

270
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 21%

$35
Average prescription price

Avg: $51

ROBERT MCDONALD MD

Otolaryngology

688

$51.4K

180
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 21%

$75
Average prescription price

Avg: $51

PETER SHAPIRO M.D.

Otolaryngology

668

$41.3K

261
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 21%

$62
Average prescription price

Avg: $51

MARK STROBLE M.D.

Otolaryngology

645

$36.5K

236
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 21%

$57
Average prescription price

Avg: $51

MATTHEW BEUERLEIN MD

Otolaryngology

608

$44.2K

186
165 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 21%

$73
Average prescription price

Avg: $51

MARTIN WILLMAN M.D.

Otolaryngology

593

$22K

201
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 21%

$37
Average prescription price

Avg: $51

AVON COFFMAN DO

Otolaryngology

587

$24.9K

231
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 21%

$42
Average prescription price

Avg: $51

KAREN BOONE M.D.

Otolaryngology

571

$39.3K

190
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 21%

$69
Average prescription price

Avg: $51

JAMES BRAWNER M.D.

Otolaryngology

567

$21.2K

239
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 10%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 21%

$37
Average prescription price

Avg: $51

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank